At a $384M market cap with a Price/Sales of 0.4, the equity is trading at what superficially looks like distress-level revenue multiples, but the absence of a P/E and Forward P/E combined with an EPS of -25.4 and projected EPS of -$5.00 signals a business still deeply unprofitable with no visible earnings bridge. The Altman Z-Score of -1.8 is firmly in distress territory, and a Current Ratio of 0.5 reinforces near-term balance sheet strain. An Operating Margin of -823.30% is not cyclical weakness; it is structural dysfunction. This is not a misunderstood growth story—this is a recapitalization risk trading at a low sales multiple because the equity layer is fragile.
⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.